Developing liposomal nanomedicines for treatment of patients with neuroblastoma-Reference-Cited by-同舟云学术

Developing liposomal nanomedicines for treatment of patients with neuroblastoma

Published:2018 Issue: Volume: Page:361-411
ISSN:
Container-title:Lipid Nanocarriers for Drug Targeting
language:
Short-container-title:

Author:

Gilabert-Oriol Roger,Chernov Lina,Deyell Rebecca J.,Bally Marcel B.

Publisher

Elsevier

Reference188 articles.

1. Short-term comparative study of the cyclophosphamide genotoxicity administered free and liposome-encapsulated in mice;Abdella;Iran J. Cancer Prev.,2012

2. Formation of transition metal-doxorubicin complexes inside liposomes;Abraham;Biochim. Biophys. Acta,2002

3. In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading;Abraham;Clin. Cancer Res.,2004

4. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage;Abu Lila;J. Control. Release,2013

5. Targeted delivery to neuroblastoma of novel siRNA-anti-GD2-liposomes prepared by dual asymmetric centrifugation and sterol-based post-insertion method;Adrian;Pharm. Res.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucoadhesive nanoemulsion enhances brain bioavailability of luteolin after intranasal administration and induces apoptosis to SH-SY5Y neuroblastoma cells;International Journal of Pharmaceutics;2022-10

2. Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer;Breast Cancer Research and Treatment;2020-08-10

3. Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia;Pharmaceutical Research;2019-06-24

4. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response;International Journal of Molecular Sciences;2018-09-26